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The hemagglutinin (HA) of influenza viruses initiates infection by binding to sialic acid on the cell surface via a2,6 (human) or a2,3
(avian) linkage. The influenza neuraminidase (NA) can cleave both a2,3- and a2,6-linked sialic acids, but all influenza NAs have a marked
preference for the non-human a2,3 linkage. Recent H3N2 influenza viruses have lost the ability to agglutinate chicken red blood cells. To
determine if changes in HA specificity or affinity correlate with NA specificity or activity, we examined red cell binding and elution of a
series of H3N2 viruses. We found that the NA activity of many influenza viruses does not release binding by their HA. In some egg-adapted
strains, lack of elution correlates with low levels of viral NA activity, and these elute rapidly when bacterial NA is added. However, a Fujian-
like virus, A/Oklahoma/323/03, does not elute by its own NA or with Vibrio cholerae sialidase, and it binds to red cells pre-treated with V.
cholerae sialidase. It elutes after addition of the broad specificity Micromonospora viridifaciens sialidase. Human glycophorin inhibits A/
Oklahoma/323/03 hemagglutination 6-fold better than fetuin. We conclude that specific forms of sialic acid are used as receptor by recent
human H3N2 influenza viruses, perhaps involving branched a2,6 sialic acid or a2,8 sialic acid structures on O-linked carbohydrates. The
virus itself has no O-linked glycans, so even though the NA is not able to cleave receptors on cells, the viruses will not self-aggregate. It will
be important to monitor efficacy of neuraminidase inhibitors in case there are NA-resistant receptors in the human respiratory tract that allow
the viruses to be less dependent on NA activity.
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(J.L. Waner), gillian-air@ouhsc.edu (G.M. Air).chains terminate with sialic acid, in a2,3, a2,6, or a2,8
linkages to galactose, N-acetylgalactosamine, or N-acetyl-
glucosamine in linear or branched structures. Sialic acids in
specific linkages are recognized by sialic acid binding
proteins of many pathogens. Most pathogens bind to a2,3-
linked sialic acid, with some preferring a2,8 linkages
(Angata and Varki, 2000; Gagneux et al., 2003; Karlsson,
1995). Among the few pathogens that show a preference for
a2,6-linked sialic acids are human influenza viruses. Avian
viruses bind to a2,3-linked sialic acid (Connor et al., 1994;
Rogers et al., 1983), so adapting an avian virus to
mammalian cells is accompanied by a specificity change
from a2,3 to a2,6. There have been reports that new
pandemic viruses show altered specificity over the first few005) 12 – 20
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Matrosovich et al., 2000). Receptor binding is mediated by
the viral hemagglutinin (HA) and the binding site has been
delineated by X-ray crystallography of human and avian
HAs with bound sialylated oligosaccharides (Eisen et al.,
1997; Skehel and Wiley, 2000). The NA cleaves sialic acid
from glycoconjugates and therefore is considered a receptor-
destroying enzyme.
The activities of HA and NA were initially demonstrated
by the ability of the virus to agglutinate and elute from red
blood cells. Absence of neuraminidase activity leads to
aggregation of viruses due to the HA binding to sialic acid
on adjacent viral particles. Although it is often said that NA
activity is required to prevent viruses binding to receptors
on the cell surface, electron micrographs in two different
studies show virus aggregates far outnumber virus-cell
binding and it was concluded that virus–virus aggregation
is the reason viruses do not spread in the absence of NA
activity (Liu et al., 1995; Palese et al., 1974). If destruction
of receptors on the cell surface was the only function of NA,
then it would follow that viruses must have matched HA
and NA specificities. There is some evidence that changes in
HA receptor binding activity are accompanied by concom-
itant changes in the viral NA to maintain a functional
balance between receptor binding activity and receptor
destroying activity (Baum and Paulson, 1991; Kaverin et al.,
1998; Mitnaul et al., 2000; Wagner et al., 2000). However,
there are instances of mismatched specificity such as in
early H2N2 viruses (Baum and Paulson, 1991; Choppin and
Tamm, 1959). There are also reports that NA is required for
entry, perhaps destroying decoy receptors such as 2,3-linked
sialic acid on mucins (Matrosovich et al., 2004) or removal
of sialic acid from the vicinity of the HA binding site
(Ohuchi et al., 1995).
Recent H3N2 influenza viruses have lost the ability to
bind to chicken red blood cells. This has been reported to
result from decreased affinity for a2,6 sialic acid, so that
although there is a considerable amount of a2,6 sialic acid
on chicken red cells, the density may be too low for
agglutination (Mochalova et al., 2003; Nobusawa et al.,
2000; Thompson et al., 2004). Here we have studied the HA
and NA specificities of H3N2 viruses by measuring their
binding to and elution from red blood cells, and we found
there is a mismatch in NA and HA specificities in ‘‘Fujian-
like’’ H3N2 viruses. This study shows the possibility of an
altered receptor in these recent viruses.Results
In the early winter of 2003 there was a significant
outbreak of H3N2 influenza throughout North America, and
we obtained 4 Oklahoma City isolates cultured in primary
rhesus monkey kidney cells (P0 and P1) from throat swabs.
The four isolates have the same binding and elution
properties and we have focused studies on one isolate froma young child, A/Oklahoma/323/03. This virus grows
robustly in MDCK cells (107 TCIU or 108–9 particles per
105 cells). The HA and NA gene sequences were
determined by sequencing RT-PCR products and compared
to sequences in the Influenza Sequence Database (Macken
et al., 2001). The HA1 amino acid sequence is 99.4%
identical to A/Fujian/411/02 and 100% identical to A/New
York/50/03. There is less identity to A/Panama/2007/99
(97.9%) or A/California/7/2004 (98.2%). The NA head
domain sequence is 99.7% identical to A/NewYork/50/03.
NA sequences of Fujian/02 and California/04 are not in the
databases, but A/OK/323/03 NA is 97.0% identical to A/
Wyoming/3/2003, 97.0% to A/Wellington/1/2004, and
96.4% to Panama/2007/99.
Failure to elute from red blood cells
In common with other Fujian-like viruses, Oklahoma/
323/03 proved refractory to adaptation to grow in chicken
eggs and does not agglutinate chicken red blood cells. It
agglutinates human red cells but does not elute from them,
meaning that the NA activity does not cleave the receptor
bound by the HA. We therefore carried out a series of
detailed experiments to determine the red cell binding and
elution properties of Oklahoma/323/03 and a panel of H3N2
viruses isolated earlier: Memphis/1/71, Udorn/307/72,
Victoria/3/75, Philippines/2/82, Leningrad/360/86, Beijing/
353/89, Oklahoma City isolates 3003, 5098 from 1996, and
Memphis/31/98.
Red cells were agglutinated at 4 -C and elution observed
at 26 -C at 2 h and overnight (Table 1). Only a few viruses
(Mem/71, 5098/96 and Mem/98) eluted from red blood cells
by the action of their NA, as shown by elution at 26 -C and
failure to rebind when the wells were mixed and chilled
again. When viruses were grown in eggs, Udorn/72 and
3003/96 also eluted and failed to rebind. MDCK-grown
Victoria/75, Udorn/72, and 3003/96 completely or partially
rebound to red cells, indicating that elution was the result of
low affinity rather than removal of receptors by NA
cleavage. Philippines/2/82, Leningrad/360/86, Beijing/353/
89, Oklahoma/323/03, and OK/Tf/03 bind very tightly to
red blood cells and do not elute at all either by thermal
motion or with their own NA activity. We also screened the
egg-grown vaccine strains Sydney/97, Panama/99, and
Wyoming/03 and found they also fail to elute from human
red cells. We initially studied elution at 37 -C but cell lysis
at this temperature confuses the results. Elution was a little
faster but not more extensive at 37 -C than at 26 -C, so we
used the lower temperature for the detailed studies.
Levels of NA activity
To determine if failure to elute is due to insufficient NA
activity, we measured the level of NA activity in the viruses
relative to HA titer. The NA/HA results are expressed
relative to Udorn/72 (Table 1) and while the ratio itself does
Table 2





Elution by Vch sialidase Elution by Mvi sialidase
H3N2 H1N1 H3N2 H1N1
Beijing/89 OK/03 OK/01 Beijing/89 OK/03 OK/01
100 Ya N Y Y Y Y
10 Y N N Y Y Y
1 N N N Y N N
0.1 N N N Y N N
0 N N N N N N
a Y = elutes, N = no elution.
Table 1
Elution of H3N2 viruses from human red blood cellsa
Virus MDCK-grown virus Egg-grown virus
NAMUN/HA
(relative to Udorn/72)




Self-elution Rebinding Vch sialidase
elution
Memphis/71 0.6 T 0.2 slowb no fast fast slow no fast
Udorn/72 1.0 slow partial fast fast slow no fast
Victoria/75 1.7 T 0.2 slow yes fast fast – c – –
Philippines/82 0.08 T 0.05 no n/ad fast fast no n/a fast
Leningrad/86 0.1 T 0.07 no n/a slow fast – – –
Beijing/89 0.2 T 0.06 no n/a fast fast no n/a fast
3003/96 1.0 T 0.4 slow partial fast fast slow no fast
5098/96 3.1 T 0.19 fast no fast fast n/a n/a n/a
Mem/98 (HG) 1.8 T 0.3 slow no fast fast slow no fast
Memphis/98 2.2 T 0.8 slow no fast fast neae n/a n/a
OK/323/03 1.6 T 0.3 no n/a no slow nea n/a n/a
OK/Tf/03 1.4 T 0.5 no n/a no slow nea n/a n/a
a Results shown are from 3 or more independent experiments.
b Fast: eluted within 2 h; slow: eluted overnight; no: no elution overnight.
c – = experiment not done.
d n/a = not applicable.
e nea = did not adapt to eggs.
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viruses show the relative levels of NA activity compared
to HA titer. Table 1 shows that NA activity per HA unit is
very low in vaccine strains Philippines/82, Leningrad/86,
and Beijing/89 when these are grown in MDCK cells. This
presumably accounts for their failure to elute, but the 2003
Oklahoma isolates have quite high levels of NA so their
failure to elute is not due to insufficient NA activity. Vaccine
strains Panama/99 and Wyoming/03 have similar NA/HA
ratios as OK/03 and these also fail to elute (results not
shown).
Elution by broader-specificity sialidases
To further investigate the specificity of binding, we
asked if viruses that did not elute under their own NA
activity could be eluted by broader-specificity sialidases.
We tested elution by Vch sialidase which cleaves
unbranched or branched a2,3 and a2,6 and some a2,8
sialic acid (Corfield et al., 1981; Schauer, 1982) and Mvi
sialidase which cleaves a wider variety of sialic acids
including more highly branched structures and a2,8-linked
sialic acid (Air and Laver, 1995; Aisaka et al., 1991;
Schauer, 1982; Stray et al., 2000). As shown in Table 1,
viruses up until 1998 elute with Vch sialidase, but the
2003 isolates do not. Table 2 shows the effect of
increasing sialidase concentration on elution. Beijing/89
is eluted by both Vch and Mvi sialidases but requires 100-
fold more enzyme units of Vch sialidase than of Mvi.
Oklahoma/03 was eluted by Mvi sialidase at 100-fold
increase over the amount required to elute Beijing/89, and
was not eluted by Vch sialidase even at 10-fold higher
concentration than was used to elute Beijing/89.
To determine if failure to elute by Vch sialidase is due to
steric inhibition such that the enzyme cannot reach thereceptor after it is bound, we pre-treated red cells with
sialidases and tested binding. We used red cells pre-treated
with 2 mU/ml of Vch sialidase, and found that the 2003
viruses still agglutinate them, but pre-treatment of red cells
with 2 mU/ml Mvi sialidase abrogated binding. These
results mimic the elution results and show that the resistance
of the receptor to Vch digestion is a chemical resistance
rather than steric blocking by the virus.
Specificities of N2 NAs
NA activity in Table 1 was measured using a low MW
substrate, 4-methylumbelliferyl-N-acetylneuraminic acid
(MUN). To see if these results are skewed by using a
non-physiological substrate, we measured NA activity using
the high MW glycoprotein fetuin and the trisaccharide a2,6
N-acetylneuraminyllactose, calculated NA activity per HA
unit, and normalized this against Udorn/72 (Fig. 1). We
found that the NA activities of Philippines/82 and Beijing/
89 are low with all substrates, although egg-grown
Philippines/82 and Beijing/89 have more NA activity
relative to HA than the MDCK-grown viruses. Interestingly,
Fig. 2. The linkage preference of influenza N2 NAs was measured by the
thiobarbituric acid method using a2,6 and a2,3 sialyllactoses. Viruses were
grown in tissue culture (tc) or in eggs (eg). Ratios (a2,6/2,3) shown here are
an average of 5 experiments T standard deviation.
Fig. 1. NA activity of H3N2 viruses relative to HA activity. NA activity was measured by the thiobarbituric acid method using a large substrate (fetuin), a
trisaccharide (a2,6 sialyllactose), and by fluorescence using a small artificial substrate (4-methylumbelliferyl-N-acetylneuraminic acid, MUN). The activities,
as NA/HA ratios, are normalized to those of Udorn/72. The results shown are an average of 5 experiments T standard deviation.
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of NA when measured with a small substrate (MUN)
(¨80% of Udorn/72) but activity with fetuin is only 10%
that of Udorn/72. However, the low activity with a high
molecular weight substrate does not explain the inability of
OK/03 to elute from red blood cells, since it is also not
eluted by Vch sialidase.
A switch in HA specificity from the a2,3 to the a2,6
linkage of sialic acid when an influenza virus (or HA
gene) ‘‘jumps’’ from avian to human host is expected to be
accompanied by a similar change in NA specificity. There
was evidence for some change in the H2N2 and early
H3N2 viruses (Baum and Paulson, 1991; Kobasa et al.,
1999, 2001) but the change was rather minor, from 5:1 to
3:1 preference for a2,3 sialic acid cleavage. We measured
NA activities of a subset of viruses with a2,3 and a2,6
sialyllactose. Our results (Fig. 2) show that the increasing
activity for the a2,6 linkage has not been continued after
1972. In recent viruses there is a 5:1 to 6:1 favoring of
a2,3 sialic acid over the presumptive human receptor, a2,6
sialic acid.
What component(s) of the red cell surface is bound by the
Oklahoma/03 virus?
The Fujian-like virus does not bind to fetuin when
tested in a sandwich ELISA assay, but it does bind tohuman red cell membranes and to human glycophorin
(Gulati et al., 2005). To determine the difference in affinity
we measured the ability of fetuin and glycophorin to
inhibit the hemagglutinin of OK/03 and calculated the
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glutination (IC100). Fig. 3 shows that human glycophorin is
a 6-fold more potent inhibitor of hemagglutination of the
OK/323/03 virus than fetuin per sialic acid and that OK/03
has high affinity for glycophorin (IC100 22 AM). The high
affinity for glycophorin is shared by 3003/96, but the
binding entity is different since 3003/96 is eluted partially
by its own NA and completely by Vch sialidase. Affinity
for fetuin and glycophorin is low and approximately equal
for Udorn/72 and Memphis/98 (IC100  200 AM). We
resuspended the red cells in each well and left the HI
titration plate at room temperature to see if the viral NA of
OK/03 could remove sialic acid from the fetuin or
glycophorin and hence relieve the inhibition of hemag-
glutination, but it did not, confirming that the receptor is
resistant to viral NA. Viruses that do not elute from red
cells have high affinity for glycophorin and bind to sialic
acid that is resistant to the viral NA activity (Fig. 3 and
Table 1).
We compared release of sialic acid by Vch and Mvi
sialidases from purified glycophorin and fetuin. For
glycophorin there was no significant difference in either
the kinetics of release or the total sialic acid released. For
fetuin, there was a more rapid release of sialic acid by
Mvi compared to Vch sialidase, but the end points were
similar (results not shown), indicating that most of the O-
linked sugars on glycophorin are de-sialylated by Vch
sialidase and that the resistant sialic acid must be a minor
species.Fig. 3. Inhibition of H3N2 virus hemagglutination by glycophorin or fetuin.
Glycophorin or fetuin was added to the first wells and serially diluted (1:3),
then 4 HAU of virus was added to each well and incubated for 10 min at ice
before adding red blood cells. The plates were placed at 4 -C for 90 min and
the last well showing no agglutination was recorded. The IC100 is the lowest
concentration of glycophorin or fetuin that inhibited hemagglutination
completely. The results shown are an average of 4–6 experiments T
standard deviation.Discussion
We have shown that the Fujian-like virus is mismatched
in HA and NA specificity. The HA binds with high affinity
to some moiety on the surface of human red blood cells that
is highly resistant to the viral NA activity, and indeed to Vch
sialidase. It is, however, sensitive to Mvi sialidase, sugges-
ting the receptor is some form of sialic acid, a situation
reminiscent of the HB binding site on N9 NA (Air and
Laver, 1995). The NA activity of the Fujian-like OK/03
virus can cleave a2,6-linked sialic acid from a trisaccharide
but does not release the virus from red cells. A similar lack
of release from red cells in older H3N2 egg-adapted vaccine
strains appears to be due to low NA activity since these
viruses readily eluted with Vch sialidase. In contrast, the
OK/03 virus has been passaged only in mammalian cells,
has adequate levels of NA activity, and does not elute with
Vch sialidase. Comparison of NA specificity among differ-
ent H3N2 viruses for a2,3- or a2,6-linked sialic acid
showed no significant differences, indicating there is no
change in NA specificity accompanying or responsible for
altered binding specificity. Also there are no amino acid
changes near the active site pocket of NA of non-eluting
influenza viruses. All influenza NAs have a marked
preference for a2,3-linked sialic acid, and it has been
suggested that this is to remove the a2,3 sialic acid from
mucins that might otherwise trap virus before it reaches the
cell surface (Burnet, 1948; Couceiro et al., 1993). However,
we find no binding of the 2003 virus to a2,3 sialic acid (data
not shown) using a direct binding assay (Wu and Air, 2004),
in accord with other studies on binding specificity of recent
H3N2 viruses (Mochalova et al., 2003).
The loss of ability to agglutinate chicken red cells
occurred during the 1990s and has been correlated with
lower affinity for a2,6 sialic acid (Mochalova et al., 2003;
Nobusawa et al., 2000). The change to NA-resistant binding
occurred between 1998 and 2002 (Table 1). Of the 21 amino
sequence differences in HA1 between Mem/98 and Okla-
homa/03, there are 4 that have been implicated in sialic acid
specificity (Q156H, S186G, W222R, and G225D) (Eisen et
al., 1997). However, not enough structural information is
available to attribute specificity differences to these changes.
To further investigate the HA binding specificity, we
compared binding to two different glycoproteins. The OK/
03 virus binds to glycophorin in an ELISA assay but not to
fetuin (Gulati et al., 2005), and fetuin is a poor inhibitor of
hemagglutination compared to glycophorin (Fig. 3). Human
glycophorin has 16 O-linked sugar chains and only one N-
linked sugar chain in 131 amino acids (Pisano et al., 1993;
Tomita et al., 1978), while bovine fetuin has 3 O-linked and
3 N-linked glycans in 341 amino acids (Edge and Spiro,
1987; Green et al., 1988). The numbers of sialic acids are
about 30 per mole of glycophorin and about 16 per mole of
fetuin. Thus, the density of sialic acids on glycophorin is
considerably higher than on fetuin. The proportion of a2,6
sialic acid is 43% of total sialic acid in glycophorin, 42% in
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charides of glycophorin and fetuin are the same; a2,6 sialic
acid occurs in terminal and branched triantennary sugars, as
on the viral glycoproteins.
Mvi sialidase cleaves sialic acids in branched linkages,
but Vch sialidase only cleaves sialic acid linked to internal
Gal or GalNAc under certain conditions (Barton and
Rosenberg, 1973; Schauer, 1982). We digested fetuin and
glycophorin with Vch and Mvi sialidases to determine if the
Mvi enzyme cleaves the branched O-linked structures of
glycophorin more efficiently than Vch sialidase, but it did
not, suggesting that the binding is not predominantly to
NeuNAca2,3Galh1,3(NeuNAca2,6)GalNAc-, which makes
up 80% of the O-linked structures in glycophorin (Bendiak
et al., 1989; Cumming et al., 1989; Fukuda et al., 1987).
This experiment also showed that the increased binding of
Fujian-like virus to glycophorin as compared to fetuin is
not just because of increased density of sialic acid. Another
candidate is the a2,8 sialylated modification of O-linked
glycans of glycophorin (Fukuda et al., 1987), that is
cleaved more efficiently by the Mvi sialidase than the
Vch enzyme (Aisaka et al., 1991; Schauer, 1982) and binds
variants of NWS HA (Wu and Air, 2004). There may also
be contributions from modifications of ‘‘downstream’’
sugars, such as fucosylation or sulfation that might lead
to resistance to cleavage by viral and Vch NAs (Mian et al.,
1979). H5N1 chicken influenza viruses display a high
affinity for NeuAca2,3Galh1,4(6HSO3)GlcNAc- (Gam-
baryan et al., 2004), but the authors did not report if human
viruses bind sulfated structures or if the viral NA can cleave
sialic acid from sulfated structures. In any case, the major
contribution to increased binding of the OK/03 virus to
glycophorin over fetuin (Fig. 3) seems to be from O-linked
sugar chains. The virus itself has no O-linked glycans, so
viruses that bind sialic acids specific to O-linked carbohy-
drates will not self-aggregate, even though the NA is not
able to cleave the receptors on cells.
The glycoconjugates on the surface of human respiratory
tract cells do not, of course, include glycophorin, but it is
known that they do include many glycoproteins with mucin-
like O-linked carbohydrates as well as the secreted true
mucins. The mucins secreted by goblet cells contain only
a2,3-linked sialic acid (Baum and Paulson, 1990) but the
structures of O-linked glycans on other cell types are largely
unknown although they are rich in a2,6 sialic acid (Baum
and Paulson, 1990; Couceiro et al., 1993). It was recently
reported that influenza virus A/Udorn/307/72 requires host
cell N-linked glycoprotein for internalization into cells, but
the virus still bound to cells lacking N-linked glycoprotein
(Chu and Whittaker, 2004), so it is possible the essential N-
linked glycoprotein is the co-receptor that mediates the virus
entry after initial sialic acid binding (Stray et al., 2000). One
difference in recent H3N2 viruses is increased binding to
synthetic oligosaccharides containing 6Vsialyllactosamine
and loss of binding to 6Vsialyllactose (Mochalova et al.,
2003), but the significance of this observation for binding tocell surfaces is unclear since 6Vsialyllactose does not occur
in N-, O-, or lipid-linked structures.
The OK/03 virus grows efficiently in MDCK cells,
indicating either that the non-cleavable receptor is not
present, or that the virus is not dependent on receptor-
destroying activity. We tested this by growing OK/03 in
MDCK cells in the presence of oseltamivir, and found little
evidence of inhibition by this potent inhibitor of NA activity
as reported in other studies, where it has been shown that the
NA of recent viruses is sensitive to oseltamivir in the
enzymatic assay but virus replication is resistant to the drug
when tested by plaque reduction assay in MDCK cells
(Gubareva, 2004; Kiso et al., 2004; Thompson et al., 2004).
When viruses become resistant to NA inhibitors under
selection in MDCK cells, the mutation is often in the HA
rather than in the NA, lowering the affinity of HA for sialic
acid to overcome the requirement for NA (Air et al., 1999;
Bantia et al., 1998; McKimm-Breschkin et al., 1996). It has
been found that some of the viruses that are resistant in
tissue culture to NA inhibitors due to mutations in the HA
are fully sensitive in animal models, indicating a role of NA
that is distinct from its receptor-destroying activity
(McKimm-Breschkin, 2000). In accord with this, inhib-
itor-resistant HA mutants have not yet seen in clinical
studies (Gubareva, 2004). A recent report reiterates older
observations that NA activity may function in entry of
influenza viruses into cells (Matrosovich et al., 2004). NA
activity also exposes terminal galactose residues that are
receptors for secondary bacterial infection (McCullers and
Bartmess, 2003). Further understanding of the basis of this
mismatch of HA and NA activities will give us insights into
the functional receptors used in the human respiratory tract
and the role of NA in recent human H3N2 influenza viruses.
If the virus binds to a receptor that is not cleaved by
NA, and if this receptor is on O-linked glycans and
therefore not included in the glycan structures on the
virion, the need for NA activity may be reduced leading to
ineffectiveness of NA inhibitors. Thus, it will be important
to monitor efficacy of neuraminidase inhibitors in vivo in
case these changes in binding to human red cells extend to
the human respiratory tract.Materials and methods
Viruses
The viruses used in this study include A/Oklahoma/323/
03, a Fujian-like isolate; A/Memphis/31/98, a Sydney-like
isolate provided by Dr. R.G. Webster (Gulati et al., 2002);
two 1996 Oklahoma H3N2 isolates termed 3003, 5098; and
a 2003 H3N2 isolate termed Tf; Udorn/307/72 (from Dr.
Ming Luo, UAB); reassortant A/Memphis/1/71(HA)-Bel/
42(NA) (Laver et al., 1979); and vaccine strains Philippines/
2/82, Leningrad/360/86, and Beijing/353/89 (all high-
growth egg-adapted reassortants with internal genes from
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was also used in some experiments for comparison.
The viruses were grown in Madin–Darby canine kidney
(MDCK) cells (Liu and Air, 1993) or in embryonated
chicken eggs and purified by sucrose gradient centrifugation
(Laver, 1969).
Neuraminidase assays
NA activity was determined by the thiobarbituric acid
method using fetuin, a2,3 sialyllactose (3VSL) or a2,6
sialyllactose (6VSL) as substrates (Aymard-Henry et al.,
1973; Lentz et al., 1987), or by fluorescence using 4-
methylumbelliferyl-N-acetylneuraminic acid as substrate
(Potier et al., 1979).
Hemagglutination (HA) and hemagglutination-inhibition
assay (HI)
Viruses were serially diluted in 50 Al of CaMg-saline
(0.25 mM CaCl2, 0.8 mM MgCl2 in borate-buffered saline,
pH 7.2) and 50 Al of washed chicken (0.5%) or human
(0.8%) red blood cells added. The plates were kept at 4 -C
and agglutination was read at 90 min. The plates were then
left at 26 -C to monitor elution of virus from red cells (button
formation). Elution was recorded at 2 h and overnight. The
wells were then mixed gently and placed at 4 -C for 90 min
to determine if rebinding occurred, to distinguish elution due
to neuraminidase activity (no rebinding) from elution by
thermal motion disrupting weak binding (re-binds on cool-
ing). Elution by sialidase from Micromonospora viridifa-
ciens (Mvi) or Vibrio cholerae (Vch) was done by adding
the enzyme after recording the agglutination. Plates were
incubated at 26 -C for 2 h and elution recorded.
Sialidase-treated red cells were obtained by incubating
them in 2 mU/ml sialidase from M. viridifaciens (Mvi) or V.
cholerae (Vch) at 37 -C for 1 h. Then the red cells were put
on ice for 5 min. HA assays were performed at 4 -C, where
the NA activity is essentially zero.
To determine the inhibitory effect of glycophorin or
fetuin on hemagglutination, wells were filled with 50 Al of
CaMg-saline. Glycophorin (25 Al of 2 Ag/Al) or fetuin (10
Ag/Al) was added to the first wells and serially diluted (1:3),
then 25 Al of influenza virus containing 4 HA units was
added to each well. The plates were kept on ice for 10 min
and then 50 Al of 0.8% human red blood cells added. The
plates were placed at 4 -C for 90 min and the last well
showing no agglutination was recorded. The IC100 is the
concentration of glycophorin or fetuin in the highest
inhibiting dilution.
NA/HA ratios
To obtain a measure of NA activity of each virus
preparation relative to its HA activity, the fluorescence
reading generated in 20 min divided by the HA titer of 50 Alof appropriate dilution of virus was normalized to 100% for
Udorn/72. For other substrates, the absorbance reading in
the thiobarb method divided by the HA titer was compared
to that of Udorn/72 in the same way.Acknowledgments
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